Qualcomm and Arm kick off trial, potential for huge damages in focus

Chipmakers Qualcomm and Arm Holdings set the stage for a trial on Monday, as Qualcomm accused Arm of withholding vital chip testing tools. The lawsuit in a Delaware federal court claims that Arm leaked information about a potential termination of their license agreement to the media, damaging discussions for a deal between Qualcomm and Meta Platforms.

Qualcomm seeks to stop paying royalties potentially worth billions of dollars for up to five years. Their attorney, Karen Dunn, explained that the delay caused Meta to shift focus to AI eyeglasses, reducing the value of the deal by $170 million. Arm's attorney, Gregg LoCascio, argued that Meta's shift was due to a move towards AI eyeglasses rather than any harm inflicted on Qualcomm.

In a related trial, Judge Maryellen Noreika addressed whether Arm had negotiated in good faith with Qualcomm for the next version of its chip technology. Qualcomm's CEO, Cristiano Amon, testified that Arm sought an 18,500% increase in royalty payments between version 9 and version 10 of its chip architecture. Arm's attorney pressed Amon on whether the royalty structure was a result of outdated contracts from the era of smaller smartphone chips.

However, Amon maintained that the deal was not underpriced for today's market, where data center chips could have over 200 times more central processor cores. The five-day trial continues to reveal the ongoing tension between these two major chip technology firms.